COMBINED TREATMENT OF PATIENTS WITH ERECTILE DYSFUNCTION AND URINATION DISORDERS
- Authors: Kamalov A.A1, Osmolovsky B.E.1, Okhobotov D.A1, Khodyreva L.A.1, Takhirzade T.B1, Takhirzade A.M1, Gevorkyan A.R1
-
Affiliations:
- Issue: No 3 (2013)
- Pages: 29-33
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/279833
- ID: 279833
Cite item
Abstract
Full Text
About the authors
A. A Kamalov
B. E. Osmolovsky
Email: borisosm@maiI.ru
D. A Okhobotov
L. A. Khodyreva
T. B Takhirzade
A. M Takhirzade
A. R Gevorkyan
References
- Гамидов С.И., Даренков С.П., Овчинников Р.И. и др. Эректильная дисфункция у мужчин с симптомами нижних мочевых путей. Фарматека. 2010;9:12-16.
- Raizman J. et al. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur. Urol. 2012;60:809-825.
- Kaplan S.A., Gonzalez R.R., Te A.E. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction. Eur. Urol. 2007;51:1717-1723.
- Dmochowski R., Roehrborn C., Klise S. et al. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial. J. Urol. 2010.
- Porst H., Kim E.D., Casabe' A.R. et al., for the LVHJ study team. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebocontrolled trial. Eur Urol. 2011;60:1105-1113.
- Liu L., Zheng S., Han P. et al. Phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis. Urology. 2011;77:123-129.
- McVary K.T., Monnig W., Camps Jr J.L. et al. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol. 2007;177:1071-1077.
- Clinical practice guidelines. Management of BPH (revised, 2010). European Association of Urology Web site. http://www.eau.org